Personalis, Inc. (PSNL)
NASDAQ: PSNL · Real-Time Price · USD
5.00
-0.09 (-1.77%)
Nov 4, 2024, 4:00 PM EST - Market closed
Personalis Employees
As of December 31, 2023, Personalis had 225 total employees, including 223 full-time and 2 part-time employees. The number of employees decreased by 174 or -43.61% compared to the previous year.
Employees
225
Change (1Y)
-174
Growth (1Y)
-43.61%
Revenue / Employee
$355,676
Profits / Employee
-$362,009
Market Cap
283.48M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Cerus | 637 |
uniQure | 480 |
Sutro Biopharma | 302 |
ADC Therapeutics | 274 |
Lyell Immunopharma | 224 |
Genfit | 159 |
Sanara MedTech | 108 |
Design Therapeutics | 58 |
PSNL News
- 12 days ago - Personalis to Announce Third Quarter 2024 Financial Results - Business Wire
- 7 weeks ago - ESMO 2024 Data Expands on Compelling Performance of Personalis NeXT Personal® MRD Test - Business Wire
- 2 months ago - Personalis to Participate at Upcoming Investor Conferences - Business Wire
- 2 months ago - Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 2 months ago - Personalis: Resetting My Strategy Following The Q2 Beat - Seeking Alpha
- 2 months ago - Personalis and Tempus Announce Expanded Collaboration - Business Wire
- 3 months ago - Personalis, Inc. (PSNL) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Personalis Reports Second Quarter 2024 Financial Results - Business Wire